Cargando…

Determining eligibility for antiretroviral therapy in resource-limited settings using total lymphocyte counts, hemoglobin and body mass index

BACKGROUND: CD4+ T lymphocyte (CD4) cell count testing is the standard method for determining eligibility for antiretroviral therapy (ART), but is not widely available in sub-Saharan Africa. Total lymphocyte counts (TLCs) have not proven sufficiently accurate in identifying subjects with low CD4 cou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moore, David M, Awor, Anna, Downing, Robert S, Were, Willy, Solberg, Peter, Tu, David, Chan, Keith, Hogg, Robert S, Mermin, Jonathan
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1796890/ https://www.ncbi.nlm.nih.gov/pubmed/17233896 http://dx.doi.org/10.1186/1742-6405-4-1

Ejemplares similares

Utility of routine viral load, CD4 cell count, and clinical monitoring among adults with HIV receiving antiretroviral therapy in Uganda: randomised trial
por: Mermin, Jonathan, et al.
Publicado: (2011)

The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy
por: Ekwaru, John P, et al.
Publicado: (2013)

CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study
por: Kahn, James G, et al.
Publicado: (2011)

Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings
por: Kiragga, Agnes N, et al.
Publicado: (2010)

Total lymphocyte count as a surrogate marker for CD4 count in resource-limited settings
por: Obirikorang, Christian, et al.
Publicado: (2012)

The Use of Pill Counts as a Facilitator of Adherence with Antiretroviral Therapy in Resource Limited Settings
por: Achieng, Loice, et al.
Publicado: (2013)

A Novel Community Health Worker Tool Outperforms WHO Clinical Staging for Assessment of Antiretroviral Therapy Eligibility in a Resource-Limited Setting
por: MacPherson, Peter, et al.
Publicado: (2014)

Comparing Absolute Lymphocyte Count to Total Lymphocyte Count, as a CD4 T Cell Surrogate, to Initiate Antiretroviral Therapy
por: Sreenivasan, Srirangaraj, et al.
Publicado: (2011)

Absolute lymphocyte count as a marker for CD4 lymphocyte count: criterion for initiating antiretroviral therapy in HIV-infected Nigerians
por: Erhabor, Osaro, et al.
Publicado: (2009)

Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy
por: Mahy, Mary, et al.
Publicado: (2010)

Body Mass Index, Haemoglobin, and Total Lymphocyte Count as a Surrogate for CD4 Count in Resource Limited Settings
por: Kwantwi, Louis Boafo, et al.
Publicado: (2017)

Reduction in Early Mortality on Antiretroviral Therapy for Adults in Rural South Africa Since Change in CD4(+) Cell Count Eligibility Criteria
por: Lessells, Richard J., et al.
Publicado: (2014)

Development and evaluation of a clinical algorithm to monitor patients on antiretrovirals in resource-limited settings using adherence, clinical and CD4 cell count criteria
por: Meya, David, et al.
Publicado: (2009)

Absolute Lymphocyte Count Is Not a Suitable Alternative to CD4 Count for Determining Initiation of Antiretroviral Therapy in Fiji
por: Balak, Dashika A., et al.
Publicado: (2014)

Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings
por: Calmy, Alexandra, et al.
Publicado: (2012)

Is total lymphocyte count a predictor for CD4 cell count in initiation antiretroviral therapy in HIV-infected patients?
por: Abdollahi, Alireza, et al.
Publicado: (2014)

Changing Antiretroviral Eligibility Criteria: Impact on the Number and Proportion of Adults Requiring Treatment in Swaziland
por: Bock, Naomi N., et al.
Publicado: (2016)

What Is the Optimal First Line Antiretroviral Therapy in Resource-Limited Settings?
por: Kenyon, Chris, et al.
Publicado: (2012)

Time to eligibility for antiretroviral therapy in adults with CD4 cell count > 500 cells/μL in rural KwaZulu-Natal, South Africa
por: McGrath, N, et al.
Publicado: (2015)

Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting
por: Badri, Motasim, et al.
Publicado: (2008)

Factors Associated with Late Presentation of HIV and Estimation of Antiretroviral Treatment Need according to CD4 Lymphocyte Count in a Resource-Limited Setting: Data from an HIV Cohort Study in India
por: Alvarez-Uria, Gerardo, et al.
Publicado: (2012)

Trends in reported AIDS defining illnesses (ADIs) among participants in a universal antiretroviral therapy program: an observational study
por: Jafari, Siavash, et al.
Publicado: (2011)

Antiretroviral Treatment in Resource-Limited Settings 2012
por: Duerr, Ann, et al.
Publicado: (2012)

Reproductive Intentions and Outcomes among Women on Antiretroviral Therapy in Rural Uganda: A Prospective Cohort Study
por: Homsy, Jaco, et al.
Publicado: (2009)

Computed CD4 percentage as a low-cost method for determining pediatric antiretroviral treatment eligibility
por: Callens, Steven FJ, et al.
Publicado: (2008)

Absolute lymphocyte count as a surrogate marker for CD4 counts after six months of HAART initiation in a resource-limited setting in India
por: Srirangaraj, S., et al.
Publicado: (2012)

Screening HIV-infected adults in Malawi for anaemia: impact on eligibility for antiretroviral therapy
por: Page, I D, et al.
Publicado: (2013)

Proposal for Defining Eligibilities to Access CERN’s Central Computing Resources
por: Porcari, Enrica Maria
Publicado: (2022)

Incident Kaposi sarcoma during the expansion of antiretroviral therapy eligibility in Nigeria: a retrospective cohort study
por: Akanbi, Maxwell. O., et al.
Publicado: (2023)

Expanding HAART Treatment to All Currently Eligible Individuals under the 2008 IAS-USA Guidelines in British Columbia, Canada
por: Lima, Viviane D., et al.
Publicado: (2010)

Reticulocyte counts and their relation to hemoglobin levels in trauma patients
por: Otterman, M, et al.
Publicado: (2008)

Clinician Perspectives on Delaying Initiation of Antiretroviral Therapy for Clinically Eligible HIV-Infected Patients
por: Beer, Linda, et al.
Publicado: (2015)

Risk factors for mortality among malnourished HIV-infected adults eligible for antiretroviral therapy
por: Woodd, Susannah L, et al.
Publicado: (2016)

Value of the use of absolute lymphocyte as surrogate for CD4 count in resource poor situations
por: Adegbamigbe, Oluwafemi Johanson, et al.
Publicado: (2014)

CD4 Enumeration Technologies: A Systematic Review of Test Performance for Determining Eligibility for Antiretroviral Therapy
por: Peeling, Rosanna W., et al.
Publicado: (2015)

Diminishing Availability of Publicly Funded Slots for Antiretroviral Initiation among HIV-Infected ART-Eligible Patients in Uganda
por: Geng, Elvin H., et al.
Publicado: (2010)

HIV-infected presumptive tuberculosis patients without tuberculosis: How many are eligible for antiretroviral therapy in Karnataka, India?
por: Kumar, Ajay M.V., et al.
Publicado: (2017)

Longitudinal Care Cascade Outcomes Among People Eligible for Antiretroviral Therapy Who Are Newly Linking to Care in Zambia: A Multistate Analysis
por: Mody, Aaloke, et al.
Publicado: (2020)

Mortality and its association with CD4 cell count and hemoglobin level among children on antiretroviral therapy in Ethiopia: a systematic review and meta-analysis
por: Wubneh, Chalachew Adugna, et al.
Publicado: (2020)

Evaluating Total Lymphocyte Count as a Surrogate Marker for CD4 Cell Count in the Management of HIV-Infected Patients in Resource-Limited Settings: A Study from China
por: Chen, Jieqing, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_0cijpcpo5d373iqqu2s0ik8fi2